Biocom Systems, Inc. – Biocom Systems, Inc.

We can evaluate percutaneous absorption of pharmaceuticals and cosmetics

by our unique in vitro-in silico technology

Simulation software for transdermal drug delivery

SKIN-CAD®

~ Prediction of blood concentration from in vitro skin permeation data ~

SKIN-CAD users:
pharmaceutical companies and universities
in Japan, EU and US

Clients:
many pharmaceutical, cosmetic and chemical companies
in Japan

Skin permeation study / Release study

~ We can design and implement optimal in vitro studies to clients ~

*About us*	Company name: President: Established: Address:	Biocom Systems, Inc. Daisuke Mori, Ph.D. 2001-08-10 1-1 Hyakunen-koen, Kurume city, Fukuoka 839-0864, JAPAN
Partnership	Research: SKIN-CAD agent:	Hikima Lab. at Kyushu Institute of Technology (Fukuoka, JAPAN) FQS Poland Sp. z o.o. (subsidiary of Fujitsu)
SKIN-CAD®	(development & sales)	We develop and sell unique software SKIN-CAD® for transdermal and topical formulation. SKIN-CAD® can simulate skin-body pharmacokinetics based on mathematical percutaneous absorption model, predict skin permeation amount and blood concentration using various model parameters determined from in vitro data, and also analyze the effects of metabolism and binding in the skin, the enhancement by iontophoretic application, and the pharmacokinetic -pharmacodynamic model, etc.
In vitro study	(contract service)	We can perform in vitro studies such as skin permeation study and release study. (in vitro skin permeation study using vertical diffusion cell)
Diffusion cell	(sales agent)	We can sell diffusion cell products made by Climbing Co., Ltd. (Fukuoka, JAPAN)